A rare bipartisan pot proposal died a quiet death in the U.S. House that would have reclassified marijuana so that national laboratories could conduct “credible research on its safety and efficacy as a medical treatment.”
You may also like
PerkinElmer & Emerald Scientific Collaborate
Last week, just before MJBizCon, PerkinElmer announced a collaboration with Emerald Scientific...view more
Khiron Life Sciences Makes Strategic Moves In South America
Khiron Life Sciences Corp. has played an interesting game globally for some time now. Far from a...view more
Doctors & Researchers Push Medical Efficacy Forward at...view more
It is easy to forget as one steps inside this world-class medical conference (held this year in...view more
Multi-Element Analysis Using ICP-MS: A Look at Heavy...view more
Across the country and across the world, governments that legalize cannabis implement increasingly...view more
University Researchers To Study Effects of Medical Cannabis On...view more
Researchers at the University of Georgia will study the effects of legalized medical cannabis on...view more
Spotlight on Encore Labs: Servicing the Cannabis Market...view more
Encore Labs is a full-service cannabis testing lab in Pasadena, California, providing all testing...view more
University In Houston Testing Psilocybin For Treatment-Resistant...view more
On the heels of its decriminalization in a handful of US cities, psilocybin is being explored by...view more
Autism CARES Act Signed Into Law; Provides $1.8B in Funding for...view more
H.R. 1058: The Autism Collaboration, Accountability, Research, Education, and Support (CARES) Act...view more
New Study Aims To Learn If Cannabis Can Help Treat Autism
The United States Department of Defense and GW Pharmaceuticals are collaborating on a new clinical...view more
First Trials Of Cannabis Treatment For Dementia Begin in...view more
Researchers at the University of Notre Dame in Western Australia want to transform the way we treat...view more